These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27867890)

  • 41. The use of bone turnover markers for monitoring the treatment of osteoporosis in postmenopausal females undergoing total knee arthroplasty: a prospective randomized study.
    Ma R; Wu M; Li Y; Wang J; Yang P; Chen Y; Wang W; Song J; Wang K
    J Orthop Surg Res; 2021 Mar; 16(1):195. PubMed ID: 33731168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using early biomarker data to predict long-term bone mineral density: application of semi-mechanistic bone cycle model on denosumab data.
    Zheng J; van Schaick E; Wu LS; Jacqmin P; Perez Ruixo JJ
    J Pharmacokinet Pharmacodyn; 2015 Aug; 42(4):333-47. PubMed ID: 26123919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone turnover markers in postmenopausal osteoporosis and their correlation with bone mineral density and menopause duration.
    Gurban CV; Balaş MO; Vlad MM; Caraba AE; Jianu AM; Bernad ES; Borza C; Bănicioiu-Covei S; Motoc AGM
    Rom J Morphol Embryol; 2019; 60(4):1127-1135. PubMed ID: 32239087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three-month changes in bone turnover markers and bone mineral density response to raloxifene in Japanese postmenopausal women with osteoporosis.
    Majima T; Shimatsu A; Satoh N; Komatsu Y; Fukao A; Ninomiya K; Matsumura T; Nakao K
    J Bone Miner Metab; 2008; 26(2):178-84. PubMed ID: 18301975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reference intervals of bone turnover markers determined by using their curve-fitting valley for adult females in China.
    Wu XY; Zhang H; Xie H; Luo XH; Peng YQ; Yuan LQ; Dai RC; Sheng ZF; Wu XP; Liao EY
    Osteoporos Int; 2014 Mar; 25(3):943-52. PubMed ID: 23877870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of TSH suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with differentiated thyroid cancer in Northeast China: a prospective controlled cohort study.
    Wang S; Wang Y; Zhu L; He L; Lv M; Zhang H; Wang H; Zhang F; Lai Y; Li Y; Shan Z; Teng W
    Endocrine; 2023 Jan; 79(1):113-124. PubMed ID: 36089636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perirenalfat thickness is associated with bone turnover markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus.
    Wang W; Huang R; Tang PT; Tu M; Guo XL
    Front Endocrinol (Lausanne); 2022; 13():990667. PubMed ID: 36387843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishing reference intervals for bone turnover markers in the healthy shanghai population and the relationship with bone mineral density in postmenopausal women.
    Hu WW; Zhang Z; He JW; Fu WZ; Wang C; Zhang H; Yue H; Gu JM; Zhang ZL
    Int J Endocrinol; 2013; 2013():513925. PubMed ID: 23533403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical bone turnover markers in hormonal disorders in adults: a narrative review.
    Szulc P
    J Endocrinol Invest; 2020 Oct; 43(10):1409-1427. PubMed ID: 32335857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current use of bone turnover markers in the management of osteoporosis.
    Brown JP; Don-Wauchope A; Douville P; Albert C; Vasikaran SD
    Clin Biochem; 2022; 109-110():1-10. PubMed ID: 36096182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.
    Greenblatt MB; Tsai JN; Wein MN
    Clin Chem; 2017 Feb; 63(2):464-474. PubMed ID: 27940448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone turnover correlates with bone quantity but not bone microarchitecture in chronic hemodialysis.
    Dusceac R; Niculescu DA; Dobre R; Sorohan MC; Caragheorgheopol A; Tacu C; David C; Poiana C
    J Bone Miner Metab; 2020 Jul; 38(4):597-604. PubMed ID: 32144577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained.
    Eastell R; Black DM; Lui LY; Chines A; Marin F; Khosla S; de Papp AE; Cauley JA; Mitlak B; McCulloch CE; Vittinghoff E; Bauer DC;
    J Bone Miner Res; 2021 Feb; 36(2):236-243. PubMed ID: 32916023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Serum Periostin Level with Classical Bone Turnover Markers and Bone Mineral Density in Shanghai Chinese Postmenopausal Women with Osteoporosis.
    Li R; Zhu X; Zhang M; Zong G; Zhang K
    Int J Gen Med; 2021; 14():7639-7646. PubMed ID: 34764677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical Markers of Bone Turnover and their Role in Osteoporosis Diagnosis: A Narrative Review.
    Khashayar P; Meybodi HA; Amoabediny G; Larijani B
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):79-89. PubMed ID: 26246012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
    Kim H; Baek KH; Lee SY; Ahn SH; Lee SH; Koh JM; Rhee Y; Kim CH; Kim DY; Kang MI; Kim BJ; Min YK
    Osteoporos Int; 2017 Mar; 28(3):1099-1108. PubMed ID: 27866216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Bone turnover marker].
    Miura M; Satoh Y
    Nihon Rinsho; 2015 Oct; 73(10):1649-58. PubMed ID: 26529926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis.
    Eastell R; Reid DM; Vukicevic S; Ensrud KE; LaCroix AZ; Thompson JR; Thompson DD; Cummings SR
    Bone; 2012 May; 50(5):1135-40. PubMed ID: 22348983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative analysis of bone turnover markers in bone marrow and peripheral blood: implications for osteoporosis.
    Jiang C; Zhu S; Zhan W; Lou L; Li A; Cai J
    J Orthop Surg Res; 2024 Mar; 19(1):163. PubMed ID: 38429649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trabecular bone score in the hip: a new method to examine hip bone microarchitecture-a feasibility study.
    Haeri NS; Perera S; Ferreiro I; Hans D; Greenspan SL
    Arch Osteoporos; 2022 Sep; 17(1):126. PubMed ID: 36125566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.